Scott Koenig - 16 May 2022 Form 4 Insider Report for MACROGENICS INC (MGNX)

Role
President and CEO, Director
Signature
/s/ Lynn Cilinski, Attorney-in-Fact
Issuer symbol
MGNX
Transactions as of
16 May 2022
Net transactions value
$0
Form type
4
Filing time
17 May 2022, 17:20:28 UTC
Previous filing
24 Feb 2022
Next filing
20 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MGNX Common Stock Options Exercise $80,430 +53,265 +5.3% $1.51 1,049,636 16 May 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MGNX Employee stock option (right to buy) Options Exercise $80,430 -53,265 -100% $1.51 0 16 May 2022 Common Stock 53,265 $1.51 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction represents an exercise and hold of options. The shares are jointly owned with reporting person's spouse.
F2 12.5% of the shares underlying the grant became exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.